Eligard® (leuprolide acetate) is prescribed to treat the symptoms of advanced prostate cancer. This drug is given by an injection just beneath the skin every one, three, four, or six months.
When comparing Eligard vs Lupron® (leuprolide acetate), the two medications contain the same active ingredient, and both are approved for use in advanced prostate cancer. In addition, both medicines are given via subcutaneous injection.
One of the main differences between Lupron and Eligard is how often they are given. Lupron is given once a day; Eligard every one, three, four, or six months.
(Click Eligard to learn more about this specific product, including possible side effects, important information for your healthcare provider, and what to do in cases of overdose.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Eligard [package insert]. Bridgewater, NJ: sanofi-aventis U.S. LLC;2011 March.
Eligard Web site. Available at: http://www.eligard.com. Accessed June 14, 2011.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob. Accessed June 14, 2011.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed June 14, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click